<DOC>
	<DOCNO>NCT00949390</DOCNO>
	<brief_summary>Primary Objective : · The primary objective estimate prevalence use complementary alternative medicine ( CAM ) patient advanced malignancy see Phase I clinic MD Anderson Cancer Center ( MDACC ) . Secondary Objective : · Examine association prevalence CAM use demographic socioeconomic characteristic ( age , gender , race , income , education level ) , participation phase I clinical trial , disease characteristic ( diagnosis ) , patient ' perception prognosis , physician ' information permission patient ' CAM use , decision-making , type CAM use patient .</brief_summary>
	<brief_title>Complementary Alternative Medicine Usage Among Participants Enrolled Phase I Oncology Clinical Trials</brief_title>
	<detailed_description>This survey study intend estimate prevalence use CAM patient currently treat Phase I Clinical Trials Program University Texas MD Anderson Cancer Center . The survey include question socioeconomic characteristic ( age , gender , race , income , education level ) , patient ' diagnosis patient ' perception prognosis , physician ' information permission patient ' use CAM , patient ' use CAM ( yes ) , decision-making ( purpose CAM use ) , resource type CAM . Patients ask drop questionnaire box specify location completion questionnaire . Accrual expect 50-100 patient per month . This survey expect finish 6 month .</detailed_description>
	<criteria>1 ) Patients clinical diagnosis malignancy see outpatient oncology clinic . 1 ) Presence clinically relevant condition , opinion investigator/ coordinator , would interfere complete study include , limited , visual problem , cognitive impairment acute mental illness .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Advanced Cancer</keyword>
	<keyword>Advanced Malignancy</keyword>
	<keyword>Complementary Alternative Medicine</keyword>
	<keyword>CAM</keyword>
	<keyword>Investigational Cancer Therapeutics</keyword>
	<keyword>Phase I Clinical Trials</keyword>
</DOC>